Sihuan Pharmaceutical Holdings Group Ltd (SHPHF)
0.0575
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Sihuan Pharmaceutical Holdings Group Total Assets (Quarterly): 1.627B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.627B |
June 30, 2023 | 1.623B |
June 30, 2023 | 1.623B |
December 31, 2022 | 1.760B |
June 30, 2022 | 2.150B |
June 30, 2022 | 2.150B |
December 31, 2021 | 2.274B |
June 30, 2021 | 2.213B |
June 30, 2021 | 2.213B |
December 31, 2020 | 1.997B |
June 30, 2020 | 1.850B |
June 30, 2020 | 1.850B |
December 31, 2019 | 1.797B |
June 30, 2019 | 1.998B |
June 30, 2019 | 1.998B |
December 31, 2018 | 2.245B |
June 30, 2018 | 2.216B |
June 30, 2018 | 2.216B |
December 31, 2017 | 2.082B |
Date | Value |
---|---|
June 30, 2017 | 1.989B |
June 30, 2017 | 1.989B |
December 31, 2016 | 1.755B |
June 30, 2016 | 1.966B |
June 30, 2016 | 1.966B |
December 31, 2015 | 1.898B |
June 30, 2015 | 1.986B |
June 30, 2015 | 1.986B |
December 31, 2014 | 1.825B |
June 30, 2014 | 1.677B |
June 30, 2014 | 1.677B |
December 31, 2013 | 1.666B |
June 30, 2013 | 1.527B |
June 30, 2013 | 1.527B |
December 31, 2012 | 1.515B |
June 30, 2012 | 1.381B |
December 31, 2011 | 1.399B |
June 30, 2011 | 1.388B |
December 31, 2010 | 1.041B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.623B
Minimum
Jun 2023
2.274B
Maximum
Dec 2021
1.942B
Average
1.997B
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
Sinovac Biotech Ltd | 13.66B |
CASI Pharmaceuticals Inc | 75.27M |
Zai Lab Ltd | 988.44M |
Gracell Biotechnologies Inc (DELISTED) | 259.03M |
Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 902.64M |
Shareholders Equity (Quarterly) | 625.25M |
Debt to Equity Ratio | 0.2739 |
Current Ratio | 1.511 |
Net Debt Paydown Yield | -0.18% |